Testing a new drug for cryptosporidium infection in healthy adults
Part of Digestive system, Infections clinical trials.
This trial tests a new drug, EDI048, to see how well it works and how safe it is for treating cryptosporidium infection. It is for healthy volunteers who will be intentionally exposed to the infection under controlled conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 50 years old and in good health.
- Have a body mass index (BMI) between 18 and 32.
- Understand the risks of cryptosporidium infection and how to prevent spreading it to others.
- Not work in healthcare, daycare, or as a food handler.
- Not live with a pregnant woman, a child under 4, an elderly person over 65, or someone with a weakened immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows children aged 6 months to 5 years with diarrhea caused by Cryptosporidium. It aims to understand how the infection develops over time and how it affects children.
This trial tests a drug called nitazoxanide to see if it helps children clear a Cryptosporidium infection. It is looking for children who tested positive for the parasite and whose families can stay in the area for 6 months.
This trial tests an investigational medicine called CDI-988 to see if it can prevent or treat norovirus infection. Healthy adults will be intentionally exposed to a mild norovirus strain to see how the medicine works.
This study tests an experimental antibiotic called BWC0977 to see if it is safe and well-tolerated when given as single and multiple doses. It is for healthy volunteers to understand how the drug behaves in the body before moving to patient trials.
This trial studies how Clostridioides difficile (C. diff) affects healthy people by intentionally giving a controlled dose. The goal is to understand the infection better and help develop future treatments or vaccines.
This study tests whether a specially engineered yeast (taken as a pill) can safely help prevent Clostridioides difficile infection—a serious gut infection that can develop after antibiotics. Part A enrolls healthy volunteers; Part B enrolls people at higher risk (those with prior C. difficile, recent hospitalization, or recent antibiotics).
Hear when a new Cryptosporidiosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.